Inducing amenorrhea during bone marrow transplantation: A pilot study of leuprolide acetate

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 42, Issue 9, 1997, Pages 537-541

  Laufer, Marc R ^a   Townsend, Natalie L ^b   Parsons, Katherine E ^b   Brody, Kristin A ^b   Diller, Lisa R ^b   Emans, S Jean ^b   Guinan, Eva C ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

Amenorrhea; Grafting, bone marrow; Leuprolide

Indexed keywords

GONADORELIN AGONIST; LEUPRORELIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AMENORRHEA; ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; BREAST CANCER; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER FUNCTION TEST; MENSTRUATION; MYELODYSPLASTIC SYNDROME; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; THROMBOCYTOPENIA; UTERUS MYOMA;

ADOLESCENT; ADULT; AMENORRHEA; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; LEUKEMIA; LEUPROLIDE; LYMPHOMA; PILOT PROJECTS; PLATELET COUNT; UTERINE HEMORRHAGE;

EID: 0030823428     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Laufer MR, Rein MS: Treatment of abnormal uterine bleeding with gonadotropin-releasing hormone analogues. Clin Obstet Gynecol 1993;36:668-678
2. Fegan C, Poynton CH, Whittaker JA: The gut mucosal barrier in bone marrow transplantation. Bone Marrow Transplant 1990;5:373-377
3. Rabin D, McNeil LW: Pituitary and gonadal desensitization after continuous luteinizing hormone releasing-hormone infusion in normal females. J Clin Endocrinol Metab 1980;51: 873-876
4. Sennello LT, Finley RA, Chu SY, et al: Single-dose pharmacokinetics of leuprolide in humans following intravenous and subcutaneous administration. J Pharmacol Sci 1988; 75:158-160
5. Meldrum DR, Wisot A, Hamilton F, et al: Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression. Fertil Steril 1988;50:400-402
6. Ghalie R, Porter C, Radwanska E, et al: Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation. Am J Hematol 1993 42:350-353
7. Besser GM, McNeilly AS, Anderson DC, et al: Hormonal responses to synthetic Luteinizing Hormone and Follicle Stimulating Hormone in man. Br Med J 1972;3:267-271
8. Shaw RW, Fraser HM: Use of a superactive luteinizing hormone releasing hormone (LHRH) agonist in the treatment of menorrhagia. Br J Obstet Gynecol 1984;91:913-916
9. Gardner R, Shaw RW: LHRH analogues in the treatment of menorrhagia. In Dysfunctional Uterine Bleeding. Edited by RW Shaw. Carnforth, Wales, Parthenon Press, 1990, pp 149-159
10. Friedman AJ, Barbieri RL, Benacerraf BR, et al: Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin releasing-hormone agonist. Fertil Steril 1987; 48:560-564
11. Friedman AJ, Harrison-Atlas D, Barbieri RL, et al: A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata. Fertil Steril 1989;51:251-256
12. Friedman AJ: Vaginal hemorrhage associated with degenerating submucous leiomyomata during leuprolide acetate treatment. Fertil Steril 1989;52:152-154
13. Mansfield JM, Beardsworth DE, Loughlin JS, et al: Long-term treatment of central precocious puberty with a long-acting analogue of Luteinizing Hormone-Releasing Hormone. N Engl J Med 1983;309:1286-1290